Reports

Sale

Cell and Gene Therapy Cold Chain Logistics Market

Global Cell and Gene Therapy Cold Chain Logistics Market Size, Share, Growth, Forecast: By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Others; By Services Offered; By Mode of Transportation; By Holding Temperature Range; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032

Global Cell and Gene Therapy Cold Chain Logistics Market Outlook

The global cell and gene therapy cold chain logistics market size was valued at USD 1.85 billion in 2023, driven by the increasing adoption of cell and gene therapies and advancements across the globe. The market is anticipated to grow at a CAGR of 15.6% during the forecast period of 2024-2032 to achieve a value of USD 6.81 billion by 2032.

 

Cell and Gene Therapy Cold Chain Logistics: Introduction

Cell and gene therapies are used to treat diseases and disorders by using living cells and genetic material. Cell and gene therapy are the latest and uniquely designed techniques to treat people with certain medical conditions and disorders. A particular cold chain logistics is required to store and handle all the genetic material that is going to be stored in them.

 

Global Cell and Gene Therapy Cold Chain Logistics Market Analysis

Packaging logistics are specifically designed to reduce the temperature fluctuations and to maintain the required environment for a long time in terms of temperature. Cryogenic shippers and insulated containers, that provide required temperature control during the process of transportation, are also under development and are likely to aid the global cell and gene therapy cold chain logistics market growth in the coming years.

 

Additionally, increasing focus on monitoring and data management in order to achieve real-time monitoring systems and data management platforms is also a key trend in the market. This plays an important part in making sure that the integrity of cell and gene therapies is intact.

 

Global Cell and Gene Therapy Cold Chain Logistics Market Segmentations

Market Breakup by Component

  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra Low Freezers
  • Cold Chain Management Systems
  • Shipment and Storage Medium  
  • Cryogenic Packout Kits  
  • Others

 

Market Breakup by Services Offered

  • Transportation
  • Storage
  • Packaging

 

Market by Mode of Transportation

  • Air
  • Ground
  • Water

 

Market Breakup by Holding Temperature Range

  • Cryogenic
  • Refrigerated
  • Ambient
  • Others

 

Market Breakup by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Cell and Gene Therapy Cold Chain Logistics Market Overview

The growth of the market is primarily driven by the rising adoption of cell and gene therapy cold chain logistics in the healthcare sector. The increasing advancements in regenerative medicine are directly contributing to the efficient cold chain logistics solutions. Another key feature is the rising presence of several key players, who are offering specialized services in cell and gene therapy cold chain logistics. The availability of such services is significantly driving the market growth.

 

The growth of the market is also driven by the rapid developments by logistics and transportation companies, packaging manufacturers, monitoring and data management solution providers, among others. The market for cell and gene therapy cold chain logistics is an important part of the healthcare industry, which is enabling the safe and efficient delivery of innovative treatments. The global cell and gene therapy cold chain logistics market demand is expected to witness continuous growth and development due to the increasing adoption of these therapies and advancements.

 

Global Cell and Gene Therapy Cold Chain Logistics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • BioLife Solutions, Inc. 
  • United Parcel Service (Marken) 
  • AmerisourceBergen Corporation (World Courier) 
  • Catalent, Inc. 
  • Atelerix Ltd. 
  • Cryoport, Inc. 
  • Biostor Ltd. 
  • Thermo Fisher Scientific Inc. 
  • Life Science Group Ltd (LSG) 
  • Yourway Biopharma Services Company 
  • Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions) 
  • Be The Match BioTherapies

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Component
  • Services Offered
  • Mode of Transportation
  • Holding Temperature Range
  • End User
  • Region
Breakup by Component
  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra Low Freezers
  • Cold Chain Management Systems
  • Shipment and Storage Medium  
  • Cryogenic Packout Kits  
  • Others
Breakup by Services Offered
  • Transportation
  • Storage
  • Packaging
Breakup by Mode of Transportation
  • Air
  • Ground
  • Water
Breakup by Holding Temperature Range
  • Cryogenic
  • Refrigerated
  • Ambient
  • Others
Breakup by End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • BioLife Solutions, Inc. 
  • United Parcel Service (Marken) 
  • AmerisourceBergen Corporation (World Courier) 
  • Catalent, Inc. 
  • Atelerix Ltd. 
  • Cryoport, Inc. 
  • Biostor Ltd. 
  • Thermo Fisher Scientific Inc. 
  • Life Science Group Ltd (LSG) 
  • Yourway Biopharma Services Company 
  • Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions) 
  • Be The Match BioTherapies

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Cell and Gene Therapy Cold Chain Logistics Market Overview
 
    3.1    Global Cell and Gene Therapy Cold Chain Logistics Market Historical Value (2017-2023) 
    3.2    Global Cell and Gene Therapy Cold Chain Logistics Market Forecast Value (2024-2032)
4    Global Cell and Gene Therapy Cold Chain Logistics Market Landscape
    4.1    Global Cell and Gene Therapy Cold Chain Logistics Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cell and Gene Therapy Cold Chain Logistics Product Landscape
        4.2.1    Analysis by Component
        4.2.2    Analysis by Services Offered
        4.2.3    Analysis by Mode of Transportation
        4.2.4    Analysis by Holding Temperature Range
5    Global Cell and Gene Therapy Cold Chain Logistics Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cell and Gene Therapy Cold Chain Logistics Market Segmentation 
    6.1    Global Cell and Gene Therapy Cold Chain Logistics Market by Component
        6.1.1    Market Overview                             
        6.1.2    Cryogenic Shippers 
        6.1.3    Cryogenic Storage Freezers 
        6.1.4    Ultra Low Freezers
        6.1.5    Cold Chain Management Systems 
        6.1.6    Shipment and Storage Medium 
        6.1.7    Cryogenic Packout Kits 
        6.1.8    Others
    6.2    Global Cell and Gene Therapy Cold Chain Logistics Market by Services Offered
        6.2.1    Market Overview
        6.2.2    Transportation
        6.2.3    Storage
        6.2.4    Packaging
    6.3    Global Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transportation
        6.3.1    Market Overview
        6.3.2    Air
        6.3.3    Ground 
        6.3.4    Water
    6.4    Global Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature Range
        6.4.1    Market Overview
        6.4.2    Cryogenic
        6.4.3    Refrigerated
        6.4.4    Ambient
        6.4.5    Others
    6.5    Global Cell and Gene Therapy Cold Chain Logistics Market by End User
        6.5.1    Market Overview
        6.5.2    Pharmaceutical and Biotechnology Companies 
        6.5.3    Academic and Research Institutes 
        6.5.4    Others
    6.6    Global Cell and Gene Therapy Cold Chain Logistics Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Cell and Gene Therapy Cold Chain Logistics Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cell and Gene Therapy Cold Chain Logistics Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cell and Gene Therapy Cold Chain Logistics Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cell and Gene Therapy Cold Chain Logistics Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cell and Gene Therapy Cold Chain Logistics Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    BioLife Solutions, Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    United Parcel Service (Marken)
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    AmerisourceBergen Corporation (World Courier)
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Catalent, Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Atelerix Ltd.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Cryoport, Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Biostor Ltd.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Thermo Fisher Scientific Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Life Science Group Ltd (LSG)
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Yourway Biopharma Services Company
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Be The Match BioTherapies
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
18    Global Cell and Gene Therapy Cold Chain Logistics Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 1.85 billion in 2023, driven by the increasing advancements in regenerative medicine.

The market is anticipated to grow at a CAGR of 15.6% during the forecast period of 2024-2032 and reach a market value of USD 6.81 billion by 2032.

The rising advancement in regenerative medicine and increased adoption of cell and gene therapies across the globe are some of the major factors aiding the global market growth.

The increasing adoption of cell and gene therapies is a key trend in the market.

The different type of components in the market are cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment and storage medium, and cryogenic pack out kits, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is a major regional market.

The services offered in the market can be categorized into transportation, storage, and packaging.

The modes of transportation can be categorized into air, ground, and water.

The holding temperature range can be divided into cryogenic, refrigerated, and ambient, among others.

The end-users in the market include pharmaceutical and biotechnology companies, and academic and research institutes, among others.

Key players included in the market are BioLife Solutions, Inc., United Parcel Service (Marken), AmerisourceBergen Corporation (World Courier), Catalent, Inc., Atelerix Ltd., Cryoport, Inc., Biostor Ltd., Thermo Fisher Scientific Inc., Life Science Group Ltd (LSG), Yourway Biopharma Services Company, Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions), and Be The Match BioTherapies.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER